Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.46 |
| ▸ | FABP7 | O15540 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 2/20 | 0.37 |
| ▸ | MDM4 | O15151 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28030548 | 0.93 | KMT2A (0.50) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL27705197 | 0.91 | KMT2A (0.50) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL7720044 | 0.90 | KMT2A (0.58) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL27564317 | 0.89 | KMT2A (0.48) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL7036852 | 0.88 | KMT2A (0.58) | KMT2AFABP5FABP7CA1CA2 | |
| Cysteamine SCHEMBL28990896 | 0.87 | KMT2A (0.47) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL30988970 | 0.87 | KMT2A (0.54) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL15058849 | 0.86 | KMT2A (0.55) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL12440444 | 0.85 | KMT2A (0.58) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL29171841 | 0.84 | KMT2A (0.44) | KMT2AFABP5FABP7CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735621-A1 | NUCLEIC ACID SYNTHESIS ON REUSABLE SUPPORT | DNA Script (FR) | 2026-05-06 | — | — | EP | disclosed |
| US-20260028671-A1 | Sequencing by Structure Assembly | HARVARD COLLEGE (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250345792-A1 | DEVICES AND METHODS FOR ANALYZING BIOLOGICAL SAMPLES | CELLANOME. INC. | 2025-11-13 | — | — | US | disclosed |
| US-12467086-B2 | Sequencing by structure assembly | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-11-11 | — | — | US | disclosed |
| EP-4642926-A1 | SPATIALLY BARCODED SURFACES | Cellanome, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| US-20250320542-A1 | SPATIALLY BARCODED SURFACES | CELLANOME INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-12421628-B2 | Massively parallel enzymatic synthesis of nucleic acid strands | DNA SCRIPT (FR) | 2025-09-23 | — | — | US | disclosed |
| US-20250243479-A1 | BARCODED BEADS FOR SPATIAL ANALYSIS OF BIOMOLECULES | MACEVICZ STEPHEN (US) | 2025-07-31 | — | — | US | disclosed |
| US-20250215617-A1 | MASSIVELY PARALLEL ENZYMATIC SYNTHESIS OF NUCLEIC ACID STRANDS | DNA SCRIPT (FR) | 2025-07-03 | — | — | US | disclosed |
| WO-2025072571-A1 | CELL CULTURE WITHIN MICROFLUIDIC STRUCTURES | Cellanome, Inc. (US) | 2025-04-03 | — | — | WO | disclosed |
| US-20060194214-A1 | Methods for assembly of high fidelity synthetic polynucleotides | CODON DEVICES, INC. | 2006-08-31 | — | — | US | disclosed |
| US-20060127920-A1 | Polynucleotide synthesis | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2006-06-15 | — | — | US | disclosed |
| WO-2006044956-A1 | METHODS FOR ASSEMBLY OF HIGH FIDELITY SYNTHETIC POLYNUCLEOTIDES | CODON DEVICES, INC. (US) | 2006-04-27 | — | — | WO | disclosed |
| WO-2005089110-A2 | POLYNUCLEOTIDE SYNTHESIS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-09-29 | — | — | WO | disclosed |
| EP-1159285-B1 | METHODS AND COMPOSITIONS FOR ECONOMICALLY SYNTHESIZING AND ASSEMBLING LONG DNA SEQUENCES | METRIGEN INC (US) | 2005-05-25 | — | — | EP | disclosed |
| US-20030232382-A1 | Method and apparatus for performing large numbers of reactions using array assembly | BRENNAN THOMAS M (US) | 2003-12-18 | — | — | US | disclosed |
| US-6632641-B1 | Filling wells in solid supports with reactants; releasing polynucleotides into solution in wells; amplification | METRIGEN, INC. | 2003-10-14 | — | — | US | disclosed |
| US-20030186226-A1 | Methods and compositions for economically synthesizing and assembling long DNA sequences | MOLINARI, ROBERT J., PH.D. AS COLLATERAL AGENT | 2003-10-02 | — | — | US | disclosed |
| EP-1159285-A1 | METHODS AND COMPOSITIONS FOR ECONOMICALLY SYNTHESIZING AND ASSEMBLING LONG DNA SEQUENCES | Protogene Laboratories, Inc. (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000053617-A1 | METHODS AND COMPOSITIONS FOR ECONOMICALLY SYNTHESIZING AND ASSEMBLING LONG DNA SEQUENCES | PROTOGENE LABORATORIES, INC. (US) | 2000-09-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028671-A1 | Sequencing by Structure Assembly | POLL, CPSF7, POLM | KMT2A 3296/4885FABP5 2995/4885FABP7 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.